Cardiologist @BrighamWomens @harvardmed Cardio-OB & women's health. Prior IM and Chief Resident @WeillCornell. | orgullosamente @UNALOficial y Cucuteña 🇨🇴

Joined October 2010
32 Photos and videos
Maria A. Pabón, MD retweeted
We had the priviledge of authoring this editorial for @JACCJournals on Secondary analysis of SOGALDI - PEF with Professor Bertram Pitt. sciencedirect.com/science/ar…
2
15
44
4,291
Maria A. Pabón, MD retweeted
Its a wrap! Fantastic 2nd annual @ISHVnews and @MGBWomenHeart women’s CVH YIA. Congratulations to all the participants and their mentors! @CedarsSinai @nyulangone @MayoClinic @HMethodistCV @TCHheart @EmoryUniversity. Dr Bairey Merz @mchonig @NanditaScottMD @emilyswlau @sarma_amy
1
16
54
3,572
Maria A. Pabón, MD retweeted
"Medicine can have extraordinary meaning. But it cannot substitute for being present in your own life." In #APieceofMyMind, a psychiatrist and residency program director reflects on an unexpected #LungCancer diagnosis. ja.ma/48OxHxC
5
262
586
247,503
Maria A. Pabón, MD retweeted
Our latest in @JAMACardio led by Jan Hemeryck (@KU_Leuven @MGHHeartHealth @broadinstitute ). Hypertensive disorders of 🤰 (HDP) are strongly associated w/ ➡️ chronic HTN. Can quantifying HTN genetic 🧬 risk further stratify those at highest risk? jamanetwork.com/journals/jam… (1/X)
1
5
27
1,219
Maria A. Pabón, MD retweeted
New paper in @CircAHA 🫀📊 In older adults, poor CKM health was highly prevalent, with ~88% in stage 3–4. ⬆️ CKM stage → worse 🫀 remodeling higher HF risk 📈 Stage 4 vs 2: >8x higher risk over ~9 years Link: ahajournals.org/doi/10.1161/… @mvaduganathan @TorBiering @CTCPR_
19
42
3,547
Maria A. Pabón, MD retweeted
Congrats to the @iSCADregistry team on this publication in @JAMACardio today as simultaneous publication to presentation at #ACC26 @AkoczoAgnes @SCADalliance @NanditaScottMD @drmalissawood
Among women with #PSCAD, compared to #NPSCAD, rates of assisted reproductive technology use, #preeclampsia, #multigravidity, and severe acute #coronary events were higher; LVEF recovery was less likely at 1 year. #ACC2026 @ACCinTouch ja.ma/4sPOAzW
9
30
3,173
Maria A. Pabón, MD retweeted
Among women with #PSCAD, compared to #NPSCAD, rates of assisted reproductive technology use, #preeclampsia, #multigravidity, and severe acute #coronary events were higher; LVEF recovery was less likely at 1 year. #ACC2026 @ACCinTouch ja.ma/4sPOAzW
19
35
8,219
Lp(a)-related VTE risk is not uniform & appears hormone-dependent: signal in premenopausal👩‍🦰and postmenopausal👩‍🦰on MHT, but not in👨‍🦰. Sim pub with #ACC.26 @ehj_ed. Congrats @daniel_ezt and 🙏 to co-authors & my co-senior author, mentor & friend @mchonig  academic.oup.com/eurheartj/a…
1
5
26
895
Maria A. Pabón, MD retweeted
Excited to see this out! Huge thanks to my amazing mentors @mchonig and @mapabonp, and to the whole team!
Now in @ehj_ed #EHJ simutaneous with #ACC26, our analysis of Lp(a) and VTE risk led by ⭐️🇧🇪 @daniel_ezt Take-🏠: Elevated Lp(a) is associated w/ ⬆️ VTE 🩸 in high-estrogen states (premenopausal 👭, postmenopausal 👭 using hormone therapy) Paper here: academic.oup.com/eurheartj/a…
1
6
289
Maria A. Pabón, MD retweeted
Now in @ehj_ed #EHJ simutaneous with #ACC26, our analysis of Lp(a) and VTE risk led by ⭐️🇧🇪 @daniel_ezt Take-🏠: Elevated Lp(a) is associated w/ ⬆️ VTE 🩸 in high-estrogen states (premenopausal 👭, postmenopausal 👭 using hormone therapy) Paper here: academic.oup.com/eurheartj/a…
2
13
32
2,188
New: @ehj_ed @ESC_Journals in FINE-HEART, 👩‍🦰 with CKM sx had a ⬆️ burden of multimorbidity but ⬇️ likely to receive indicated CKM therapies than 👨‍🦰, despite similarly high risks of adverse outcomes. Finerenone had similar benefits. @mvaduganathan academic.oup.com/eurheartj/a…
2
6
35
2,284
APOs and cardiometabolic risk are tightly linked. In our new HCHS/SOL analysis published in @AJPCardio, preconception cardiometabolic abnormalities were associated with higher odds of APOs, with a clear dose response by metabolic syndrome burden. @OdaymeMD sciencedirect.com/science/ar…
1
2
14
1,128
Maria A. Pabón, MD retweeted
Our analysis of aldosterone parameters and CVD outcomes in ARIC is now online 👇
Higher aldosterone-renin ratios in older adults were linked to increased risk of atrial fibrillation and ischemic stroke, supporting the aldosterone pathway as a target for cardiovascular disease prevention. ja.ma/4seQLMK
2
9
916
🫶
Fantastic holiday party / “Yankee swap” 🎁🔄🎁 held jointly with the @pnatarajanmd @aklfahed @ZhiYu_ACGT labs at @MGHHeartHealth @broadinstitute. Lucky to work and collaborate with this amazing crew!
8
816
Maria A. Pabón, MD retweeted
What an incredible day at the MGB SCAD symposium this past October 🎉 Co-hosted by the MGB Women's Heart Health Program and the SCAD Alliance, we brought together 220 participants from 10 states and 6 countries for a SCAD patient-centered symposium.💙🌎
3
13
986
Maria A. Pabón, MD retweeted
Thrilled to welcome our new incoming Cardiology Fellows! 🎓❤️ Can’t wait to see the talent, curiosity, and compassion you’ll bring to the program. Here’s to years of learning, teamwork, and advancing heart care together. #CardioTwitter #MedTwitter
3
33
386
58,791
Maria A. Pabón, MD retweeted
Lots of confusion about menopausal hormone therapy right now —who should get it, when to start, and what is the🫀 risk? Our new review led by @BrighamMedRes Ruby Guo covers timing, route, and CV risk stratification for midlife women. 🔗: rdcu.be/eSUqJ
11
71
220
27,872
Maria A. Pabón, MD retweeted
Profesor Luis Enrique Caro Henao. El Maestro. Su última lección. 3 de diciembre de 2025 Facultad de Medicina Universidad Nacional de Colombia
8
28
84
2,080
Maria A. Pabón, MD retweeted
🫀 Does sex matter in response to aficamten? In SEQUOIA-HCM, women with obstructive #HCM were older & had worse baseline status (↑NT-proBNP, ↑LVOT gradients, ↓pVO₂) — yet showed similar improvements in pVO₂, LVOT gradient, and KCCQ as men. #AHA25 @SheilaHegde @wendywangmd
1
2
5
912